Top Healthcare Stocks Worth Watching – February 05th

Alphabet, UnitedHealth Group, Tempus AI, Merck & Co., Inc., Amgen, Workday, and ServiceNow are the seven Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are investments in publicly traded companies within the healthcare industry, including pharmaceutical companies, medical device manufacturers, healthcare providers, and health insurance companies. These stocks represent ownership in companies that contribute to healthcare services and products, and their performance is influenced by factors such as regulatory changes, drug approvals, and overall trends in the healthcare sector. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

Alphabet (GOOGL)

Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, devices, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube.

Alphabet stock traded down $15.40 during mid-day trading on Wednesday, hitting $190.98. 44,701,141 shares of the company’s stock traded hands, compared to its average volume of 26,727,107. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.95 and a quick ratio of 1.95. The firm has a 50 day simple moving average of $190.39 and a two-hundred day simple moving average of $174.40. Alphabet has a fifty-two week low of $130.66 and a fifty-two week high of $207.05. The stock has a market cap of $2.34 trillion, a price-to-earnings ratio of 25.31, a P/E/G ratio of 1.31 and a beta of 0.99.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Shares of NYSE:UNH traded down $9.24 during trading on Wednesday, reaching $536.22. 2,507,171 shares of the stock were exchanged, compared to its average volume of 4,370,820. The stock has a 50-day moving average price of $533.81 and a 200-day moving average price of $564.94. The firm has a market cap of $493.47 billion, a PE ratio of 34.61, a PEG ratio of 1.48 and a beta of 0.61. UnitedHealth Group has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Shares of NASDAQ TEM traded up $7.54 during midday trading on Wednesday, reaching $69.39. The company’s stock had a trading volume of 17,932,202 shares, compared to its average volume of 11,074,773. The business’s 50 day moving average price is $44.20 and its two-hundred day moving average price is $48.58. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI has a fifty-two week low of $22.89 and a fifty-two week high of $79.49.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

MRK traded down $0.64 on Wednesday, hitting $90.10. 10,157,486 shares of the stock were exchanged, compared to its average volume of 12,754,146. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.36 and a quick ratio of 1.15. Merck & Co., Inc. has a 12 month low of $87.33 and a 12 month high of $134.63. The firm has a market capitalization of $227.92 billion, a price-to-earnings ratio of 18.85, a PEG ratio of 1.20 and a beta of 0.38. The business has a 50-day moving average of $99.58 and a two-hundred day moving average of $107.12.

Amgen (AMGN)

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout.

Shares of NASDAQ AMGN traded up $15.85 during trading hours on Wednesday, hitting $304.87. 2,989,658 shares of the stock were exchanged, compared to its average volume of 3,124,645. Amgen has a 1-year low of $253.30 and a 1-year high of $346.85. The company has a market cap of $163.88 billion, a PE ratio of 39.04, a price-to-earnings-growth ratio of 2.87 and a beta of 0.56. The company has a debt-to-equity ratio of 7.55, a quick ratio of 0.96 and a current ratio of 1.32. The company’s fifty day simple moving average is $271.14 and its two-hundred day simple moving average is $303.52.

Workday (WDAY)

Workday, Inc. provides enterprise cloud applications in the United States and internationally. Its applications help its customers to plan, execute, analyze, and extend to other applications and environments to manage their business and operations. The company offers a suite of financial management applications to maintain accounting information in the general ledger; manage financial processes, such as payables and receivables; identify real-time financial, operational, and management insights; enhance financial consolidation; reduce time-to-close; promote internal control and auditability; and achieve consistency across finance operations.

Shares of WDAY traded up $15.07 during midday trading on Wednesday, hitting $274.80. The company’s stock had a trading volume of 2,737,079 shares, compared to its average volume of 1,971,717. The company has a quick ratio of 2.05, a current ratio of 2.05 and a debt-to-equity ratio of 0.35. Workday has a one year low of $199.81 and a one year high of $311.28. The stock has a market capitalization of $73.10 billion, a price-to-earnings ratio of 45.63, a price-to-earnings-growth ratio of 4.73 and a beta of 1.35. The company’s fifty day simple moving average is $260.70 and its two-hundred day simple moving average is $249.53.

ServiceNow (NOW)

ServiceNow, Inc. provides end to-end intelligent workflow automation platform solutions for digital businesses in the North America, Europe, the Middle East and Africa, Asia Pacific, and internationally. The company operates the Now platform for end-to-end digital transformation, artificial intelligence, machine learning, robotic process automation, process mining, performance analytics, and collaboration and development tools.

ServiceNow stock traded up $15.37 during midday trading on Wednesday, reaching $1,025.50. The company’s stock had a trading volume of 590,041 shares, compared to its average volume of 1,688,507. The business has a 50-day moving average price of $1,081.85 and a 200-day moving average price of $961.18. ServiceNow has a 52 week low of $637.99 and a 52 week high of $1,198.09. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.15. The stock has a market cap of $211.25 billion, a PE ratio of 150.41, a price-to-earnings-growth ratio of 4.74 and a beta of 0.99.